期刊文献+

2-氨基苯腈合成拉帕替尼药物中间体工艺 被引量:1

Synthesis of Rapatinib Drug Intermediate by 2-amino Benzonitrile
下载PDF
导出
摘要 以2-氨基苯腈为起始原料,制备靶向抗肿瘤药物拉帕替尼重要中间体N-(3-氯-4-(3-氟苄氧基)苯基)-6-溴喹唑啉-4-胺。2-氯-4硝基苯酚和间氟苄氯通过Williamson缩合在Zn/NH 4Cl还原体系下制备3-氯-4-(3-氟苯甲氧基)苯胺;2-氨基苯氰通过碘代反应制备2-氨基-5碘苯腈;2-氨基-5碘苯腈在DMF-DME体系下进行胺-醛缩合得到N′-(4-碘-2-氰基苯基)-N,N-二甲基甲酰胺;N′-(4-碘-2-氰基苯基)-N,N-二甲基甲酰胺与3-氯-4-(3-氟苯甲氧基)苯胺经Dimroth重排得到目标产物;通过熔点测定、LC-MS、 1H-NMR确定产物。为提高碘化效率,对3种碘化体系进行评价,其中NH2I/H2O2碘化体系虽反应耗时较长,但产物转化率和选择性较为理想,反应90 h,2-氨基苯腈转化率63%,选择性91.2%,较为符合绿色化学的要求。 The preparation of N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-bromoquinazole,an important intermediate for the targeted antitumor drug lapatinib,starts with 2-aminobenzonitrile porphyrin-4-amine. 2-chloro-4-nitrophenol and m-fluorobenzyl chloride were prepared in Zn/NH 4Cl reduction system to prepare 3-chloro-4-(3-fluorobenzyloxy) aniline;2-aminobenzene cyanide was subjected to iodine reaction preparation of 2-amino-5iodobenzonitrile;2-amino-5iodobenzonitrile under amine-aldehyde condensation in DMF-DME system to give N′-(4-iodo-2-cyanophenyl)-N, N-Dimethylformamide;N′-(4-iodo-2-cyanophenyl)-N,N-dimethylformamide and 3-chloro-4-(3-fluorobenzyloxy) aniline via Dimroth rearrangement. The rearrangement gave the desired product which was determined by melting point,LC-MS,1H-NMR. In order to improve the efficiency of iodine,three kinds of iodine systems were evaluated. The NH2I/H2O2 iodine system takes a long time to react,but the conversion and selectivity of the product are ideal. The reaction rate is 90h,and the conversion rate of 2-aminobenzonitrile is 63%,selectivity 91.2%,these are more in line with the requirements of green chemistry.
作者 张宏 王艳戎 罗兰 李子成 ZHANG Hong;WANG Yanrong;LUO Lan;LI Zicheng(Department of Chemical Engineering,Sichuan Vocational College of Chemical Industry,Luzhou 646099,Sichuan,China;Department of Science and Technology Industry,Luzhou Vocational and Technical College,Luzhou 646000,Sichuan,China;School of Chemical Engineering,Sichuan University,Chengdu 610065,China)
出处 《实验室研究与探索》 CAS 北大核心 2019年第6期49-53,共5页 Research and Exploration In Laboratory
关键词 2-氨基苯腈 中间体 Dimroth重排 2-aminobenzonitrile intermediate Dimroth rearrangement
  • 相关文献

参考文献7

二级参考文献74

  • 1方岩雄,张永成,陈敏敏,郑穗华,张焜.抗肿瘤药物白花蛇舌草及其活性成分[J].中成药,2004,26(7):577-579. 被引量:39
  • 2Liao JJ. Molecular recognition of protein kinase binding pockets for design of potent and selective kinase inhibitors [ J ]. J Med Chem,2007,50 ( 3 ) :409 - 424.
  • 3Johnston SRD, Leafy A. Lapatinib:a novel EGFR/HER2 tyrosine kinase inhibitor for cancer[J].Drugs Today,2006,42 (7) : 441 - 453.
  • 4Petrov KG, Zhang Y-M, Carter M,et al. Optimization and SAR for dual ErbB-1/ErbB-2 tyrosine kinase inhibition in the 6-furanylquinazoline series [ J ]. Bioorg Med Chem Lett,2006,16 ( 17 ) : 4 686 -4 691.
  • 5Sardon T, Cottin T, Xu J, et al. Development and biological evaluation of a novel aurora A kinase inhibitor[ J]. Chembiochem, 2009,10(3) :464 - 478.
  • 6Wallace E, Vile S, Zhao Q, et al. Cyanoguanidines and cyanoamidines as ErbB2 and EGFR inhibitors: US,7488823 [ P]. 2009- 02-10[2010-03-16].
  • 7Hudson AT, Topolov G, Barraclough P, et al. Substituted heteroaromatic compounds and their ues in medicine: WO,9609294 [ P ]. 1996-03-28 [ 2010-03-161.
  • 8Nishino S, Hirotsu K, Shima H, et al. Process for producing 4-aminoquinazoline compound : US, 2005130995 [ P ]. 2005-06-16 [2010-03-16].
  • 9McClure MS, Osterhout MH, Roschangar F, et al. A practical one-pot synthesis of 5-aryl-2-furaldehydes [ J ]. Synthesis, 2001, (11):1 681 -1 685.
  • 10McClure MS, Osterhout MH, Roschangar F, et al. Quinazoline ditosylate salt compounds : US, 7157466 [ P ]. 2007-01-02 [ 2010- 03-16].

共引文献144

同被引文献6

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部